K. De Boeck

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial

An S. De Vriese, Rogier Caluwé, Hans Van Der Meersch et al. · Journal of the American Society of Nephrology · 2021 · 187 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study

An S. De Vriese, Rogier Caluwé, Lotte Pyfferoen et al. · Journal of the American Society of Nephrology · 2019 · 175 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials

Rogier Caluwé, Lotte Pyfferoen, K. De Boeck et al. · Clinical Kidney Journal · 2015 · 88 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Type III IFN‐λ mRNA expression in sputum of adult and school‐aged asthmatics

Dominique Bullens, Ann Decraene, Ellen Dilissen et al. · Clinical & Experimental Allergy · 2008 · 63 citations

Veterinary Medicine, Immunology, Infectious Diseases +12

Efficacy and Safety of Oral Fludarabine Phosphate in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Jean François Rossi, Ambro van Hoof, K. De Boeck et al. · Journal of Clinical Oncology · 2004 · 51 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15